1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia

Opción 1: Descargar recurso

Detalles del recurso


BACKGROUND: In many randomized controlled trials, patients and doctors are more interested in the per-protocol effect than in the intention-to-treat effect. However, valid estimation of the per-protocol effect generally requires adjustment for prognostic factors associated with adherence. These adherence adjustments have been strongly questioned in the clinical trials community, especially after 1980 when the Coronary Drug Project team found that adherers to placebo had lower 5-year mortality than non-adherers to placebo. METHODS: We replicated the original Coronary Drug Project findings from 1980 and re-analyzed the Coronary Drug Project data using technical and conceptual developments that have become established since 1980. Specifically, we used logistic models for binary outcomes, decoupled the definition of adherence from loss to follow-up, and adjusted for pre-randomization covariates via standardization and for post-randomization covariates via inverse probability weighting. RESULTS: The original Coronary Drug Project analysis reported a difference in 5-year mortality between adherers and non-adherers in the placebo arm of 9.4 percentage points. Using modern approaches, we found that this difference was reduced to 2.5 (95% confidence interval: -2.1 to 7.0). CONCLUSION: Valid estimation of per-protocol effects may be possible in randomized clinical trials when analysts use appropriate methods to adjust for post-randomization variables.

Pertenece a

Digital Access to Scholarship at Harvard  


Murray, Eleanor Jane -  Hernan, Miguel Angel - 

Id.: 70870800

Idioma: inglés (Estados Unidos)  - 

Versión: 1.0

Estado: Final

Palabras claveCoronary Drug Project - 

Tipo de recurso: Journal Article  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

: open

Requerimientos técnicos:  Browser: Any - 

Relación: [References] 10.1177/1740774516634335
[References] https://www.ncbi.nlm.nih.gov/pubmed/26951361
[References] Clinical Trials: Journal of the Society for Clinical Trials

Fecha de contribución: 13-ene-2018


* Quick submit: 2018-01-04T20:22:00-0500
* Murray, Eleanor J, and Miguel A Hernán. 2016. “Adherence Adjustment in the Coronary Drug Project: A Call for Better Per-Protocol Effect Estimates in Randomized Trials.” Clinical Trials: Journal of the Society for Clinical Trials 13 (4) (March 7): 372–378. doi:10.1177/1740774516634335.
* 1740-7745
* 0000-0003-0043-4901

Otros recursos del mismo autor(es)

  1. Using Observational Data to Calibrate Simulation Models BACKGROUND: Individual-level simulation models are valuable tools for comparing the impact of clinic...
  2. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions Non-randomised studies of the effects of interventions are critical to many areas of healthcare eval...
  3. Infective endocarditis and cancer in the elderly Little is known about the magnitude of the association between infective endocarditis and cancer, an...
  4. Methods to Estimate the Comparative Effectiveness of Clinical Strategies that Administer the Same Intervention at Different Times Clinical guidelines that rely on observational data due to the absence of data from randomized trial...
  5. Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa Abstract: Background: Innovative models of care are required to cope with the ever-increasing number...

Otros recursos de la mismacolección

  1. “Once the delivery is done, they have finished”: a qualitative study of perspectives on postnatal care referrals by traditional birth attendants in Ebonyi state, Nigeria Background While 79% of Nigerian mothers who deliver in facilities receive postnatal care within 48...
  2. Health Care Providers’ Experience with a Protocol for the Identification, Treatment, and Referral of Human-Trafficking Victims Abstract The healthcare setting is thought to be one of the most promising places to identify victim...
  3. Human Trafficking Is a Public Health Issue: A Paradigm Expansion in the United States This clear-sighted reference examines the public health dimensions of labor and sex trafficking in t...
  4. Human Trafficking, Mental Illness, and Addiction: Avoiding Diagnostic Overshadowing This article reviews an emergency department-based clinical vignette of a trafficked patient with co...
  5. Ribosomal DNA copy number amplification and loss in human cancers is linked to tumor genetic context, nucleolus activity, and proliferation Ribosomal RNAs (rRNAs) are transcribed from two multicopy DNA arrays: the 5S ribosomal DNA (rDNA) ar...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.